Form:DrugProjectForm: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 207: | Line 207: | ||
| style="width: 50%;" valign=top | {{{field|adverseReactions|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|adverseReactions|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Black Box Warning= | =Black Box Warning= | ||
Line 219: | Line 217: | ||
| style="width: 50%;" valign=top | {{{field|blackBoxWarningBody|input type=textarea|editor|size=35|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}} | | style="width: 50%;" valign=top | {{{field|blackBoxWarningBody|input type=textarea|editor|size=35|default=''{{fontcolor|#FF0000|Condition Name:}}'' (Content)}}} | ||
|} | |} | ||
=Adult Indications and Dosage= | =Adult Indications and Dosage= | ||
Line 238: | Line 234: | ||
| style="width: 50%;" valign=top | {{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35|editor|default=There is limited information about ''Off-Label Non–Guideline-Supported Use'' of {{PAGENAME}} in adult patients.}}} | | style="width: 50%;" valign=top | {{{field|offLabelAdultNoGuideSupport|input type=textarea|size=35|editor|default=There is limited information about ''Off-Label Non–Guideline-Supported Use'' of {{PAGENAME}} in adult patients.}}} | ||
|} | |} | ||
=Pediatric Indications and Dosage= | =Pediatric Indications and Dosage= | ||
Line 276: | Line 270: | ||
| style="width: 50%;" valign=top | {{{field|warnings|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|warnings|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Adverse Reactions= | =Adverse Reactions= | ||
Line 294: | Line 286: | ||
}}} | }}} | ||
|} | |} | ||
=Drug Interactions= | =Drug Interactions= | ||
Line 305: | Line 295: | ||
| style="width: 50%;" valign=top | {{{field|drugInteractions|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|drugInteractions|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Use in Specific Populations= | =Use in Specific Populations= | ||
Line 356: | Line 344: | ||
| style="width: 50%;" valign=top | Body of Others section: {{{field|useInOthers|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | Body of Others section: {{{field|useInOthers|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Administration and Monitoring= | =Administration and Monitoring= | ||
Line 368: | Line 354: | ||
| style="width: 50%;" valign=top | {{{field|monitoring|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|monitoring|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=IV Compatibility= | =IV Compatibility= | ||
Line 377: | Line 361: | ||
| style="width: 50%;" valign=top | {{{field|IVCompat|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|IVCompat|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Overdose= | =Overdose= | ||
Line 386: | Line 368: | ||
| style="width: 50%;" valign=top | {{{field|overdose|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|overdose|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Pharmacology= | =Pharmacology= | ||
Line 413: | Line 393: | ||
| style="width: 50%;" valign=top | {{{field|nonClinToxic|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|nonClinToxic|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Clinical Studies= | =Clinical Studies= | ||
Line 422: | Line 400: | ||
| style="width: 50%;" valign=top | {{{field|clinicalStudies|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|clinicalStudies|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=How Supplied= | =How Supplied= | ||
Line 434: | Line 410: | ||
| style="width: 50%;" valign=top | {{{field|storage|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|storage|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Free Text for Image Section= | =Free Text for Image Section= | ||
Line 446: | Line 420: | ||
| style="width: 50%;" valign=top | {{{field|packLabel|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|packLabel|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Patient Information= | =Patient Information= | ||
Line 455: | Line 427: | ||
| style="width: 50%;" valign=top | {{{field|fdaPatientInfo|input type=textarea|size=35|editor|default=For patient information about {{PAGENAME}} from NLM, click [[{{PAGENAME}} (patient information)|here]].}}} | | style="width: 50%;" valign=top | {{{field|fdaPatientInfo|input type=textarea|size=35|editor|default=For patient information about {{PAGENAME}} from NLM, click [[{{PAGENAME}} (patient information)|here]].}}} | ||
|} | |} | ||
=Precautions with Alcohol= | =Precautions with Alcohol= | ||
Line 464: | Line 434: | ||
| style="width: 50%;" valign=top | {{{field|alcohol|input type=textarea|size=35|editor|default=Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.}}} | | style="width: 50%;" valign=top | {{{field|alcohol|input type=textarea|size=35|editor|default=Alcohol-{{PAGENAME}} interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.}}} | ||
|} | |} | ||
=Look-Alike Drug Names= | =Look-Alike Drug Names= | ||
Line 473: | Line 441: | ||
| style="width: 50%;" valign=top | {{{field|lookAlike|input type=textarea|size=35|editor}}} | | style="width: 50%;" valign=top | {{{field|lookAlike|input type=textarea|size=35|editor}}} | ||
|} | |} | ||
=Price= | =Price= | ||
{| | {| |
Revision as of 11:05, 22 May 2014